Estimation of direct medical costs related to chronic hepatitis C: A rationale for early antiviral therapy

Research output: Contribution to journalEditorial

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)745-746
Number of pages2
JournalGut and liver
Volume11
Issue number6
DOIs
Publication statusPublished - 2017 Nov

Fingerprint

Ribavirin
Chronic Hepatitis C
Secondary Prevention
Combination Drug Therapy
Antiviral Agents
Costs and Cost Analysis

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

@article{6f9c7983c4344c0487d3a5a3e654ecb5,
title = "Estimation of direct medical costs related to chronic hepatitis C: A rationale for early antiviral therapy",
author = "Kim, {Do Young}",
year = "2017",
month = "11",
doi = "10.5009/gnl17408",
language = "English",
volume = "11",
pages = "745--746",
journal = "Gut and Liver",
issn = "1976-2283",
publisher = "Joe Bok Chung",
number = "6",

}

Estimation of direct medical costs related to chronic hepatitis C : A rationale for early antiviral therapy. / Kim, Do Young.

In: Gut and liver, Vol. 11, No. 6, 11.2017, p. 745-746.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Estimation of direct medical costs related to chronic hepatitis C

T2 - A rationale for early antiviral therapy

AU - Kim, Do Young

PY - 2017/11

Y1 - 2017/11

UR - http://www.scopus.com/inward/record.url?scp=85032808557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032808557&partnerID=8YFLogxK

U2 - 10.5009/gnl17408

DO - 10.5009/gnl17408

M3 - Editorial

C2 - 29081211

AN - SCOPUS:85032808557

VL - 11

SP - 745

EP - 746

JO - Gut and Liver

JF - Gut and Liver

SN - 1976-2283

IS - 6

ER -